Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes testing a Smart AFO (ankle-foot orthosis) in combination with 5-azacitidine to improve mobility in children with cereb…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Azacitidine (azacitidine)
  • Smart AFO

Snippet

Sponsor: Shirley Ryan AbilityLab | Conditions: Cerebral Palsy | Phase 2 | Status: NOT_YET_RECRUITING